SIRT1 regulated hexokinase-2 promoting glycolysis is involved in hydroquinone-enhanced malignant progression in human lymphoblastoid TK6 cells

• Published in: Ecotoxicology and environmental safety 2022-08, Vol.241, p.113757-113757, Article 113757
• Main Authors: Chen, Yuting, Yang, Hui, Chen, Shaoyun, Lu, Zhaohong, Li, Boxin, Jiang, Tikeng, Xuan, Mei, Ye, Ruifang, Liang, Hairong, Liu, Xiaoshan, Liu, Qizhan, Tang, Huanwen
• Format: Article
• Language: English
• Subjects: Glycolysis; Hexokinase-2; Hydroquinone; Malignant progression; SIRT1
• ISSN: 0147-6513; 1090-2414
• DOI: 10.1016/j.ecoenv.2022.113757

Reprogramming of cellular metabolism is a vital event during tumorigenesis. The role of glycolysis in malignant progression promoted by hydroquinone (HQ), one of the metabolic products of benzene, remains to be understood. Recently, we reported the overexpression of sirtuin 1 (SIRT1) in HQ-enhanced malignant progression of TK6 cells and hypothesized that SIRT1 might contribute to glycolysis and favor tumorigenesis. Our data showed that acute exposure of TK6 cells to HQ for 48 h inhibited glycolysis, as indicated by reduction in glucose consumption, lactate production, hexokinase activity, and the expression of SIRT1 and glycolytic enzymes, including HIF-1α, hexokinase-2 (HK-2), ENO-1, glucose transporter 1 (Glut-1), and lactic dehydrogenase A (LDHA). Knockdown of SIRT1 or inhibition of glycolysis using the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) downregulated the levels of SIRT1 and glycolytic enzymes and significantly enhanced HQ-induced cell apoptosis, although knockdown of SIRT1 or 2-DG alone had little effect on apoptosis. Furthermore, immunofluorescence and Co-IP assays demonstrated that SIRT1 regulated the expression of HK-2, and HQ treatment caused a decrease in SIRT1 and HK-2 binding to mitochondria. Importantly, we found that glycolysis was promoted with increasing HQ treatment weeks. Long-term HQ exposure increased the expression of SIRT1 and several glycolytic enzymes and promoted malignant cell progression. Moreover, compared with the PBS group, glucose consumption and lactate production increased after 10 weeks of HQ exposure, and the protein levels of SIRT1 and HK-2 were increased after 15 weeks of HQ exposure, while those of Glut-1, ENO-1, and LDHA were elevated. In addition, SIRT1 knockdown HQ 19 cells exhibited decreased lactate production, glucose consumption, glycolytic enzymes expression, cell growth, and tumor formation in nude mice. Our findings identify the high expression of SIRT1 as a strong oncogenic driver that positively regulates HK-2 and promotes glycolysis in HQ-accelerated malignant progression of TK6 cells. [Display omitted] •Acute HQ exposure inhibited the levels of SIRT1, HK-2, and glycolysis in TK6 cells.•SIRT1 regulation of HK-2 participated in acute HQ-induced cell apoptosis.•SIRT1 elevated glycolysis and promoted carcinogenesis under long-term HQ exposure.